155 related articles for article (PubMed ID: 17105732)
1. Coactivation of the N-terminal transactivation of mineralocorticoid receptor by Ubc9.
Yokota K; Shibata H; Kurihara I; Kobayashi S; Suda N; Murai-Takeda A; Saito I; Kitagawa H; Kato S; Saruta T; Itoh H
J Biol Chem; 2007 Jan; 282(3):1998-2010. PubMed ID: 17105732
[TBL] [Abstract][Full Text] [Related]
2. NF-YC functions as a corepressor of agonist-bound mineralocorticoid receptor.
Murai-Takeda A; Shibata H; Kurihara I; Kobayashi S; Yokota K; Suda N; Mitsuishi Y; Jo R; Kitagawa H; Kato S; Saruta T; Itoh H
J Biol Chem; 2010 Mar; 285(11):8084-93. PubMed ID: 20054001
[TBL] [Abstract][Full Text] [Related]
3. Ubc9 and Protein Inhibitor of Activated STAT 1 Activate Chicken Ovalbumin Upstream Promoter-Transcription Factor I-mediated Human CYP11B2 Gene Transcription.
Kurihara I; Shibata H; Kobayashi S; Suda N; Ikeda Y; Yokota K; Murai A; Saito I; Rainey WE; Saruta T
J Biol Chem; 2005 Feb; 280(8):6721-30. PubMed ID: 15611122
[TBL] [Abstract][Full Text] [Related]
4. Coactivation of SF-1-mediated transcription of steroidogenic enzymes by Ubc9 and PIAS1.
Suda N; Shibata H; Kurihara I; Ikeda Y; Kobayashi S; Yokota K; Murai-Takeda A; Nakagawa K; Oya M; Murai M; Rainey WE; Saruta T; Itoh H
Endocrinology; 2011 Jun; 152(6):2266-77. PubMed ID: 21467194
[TBL] [Abstract][Full Text] [Related]
5. Sumoylation and proteasomal activity determine the transactivation properties of the mineralocorticoid receptor.
Tirard M; Almeida OF; Hutzler P; Melchior F; Michaelidis TM
Mol Cell Endocrinol; 2007 Mar; 268(1-2):20-9. PubMed ID: 17314004
[TBL] [Abstract][Full Text] [Related]
6. Ubc9 interacts with chicken ovalbumin upstream promoter-transcription factor I and represses receptor-dependent transcription.
Kobayashi S; Shibata H; Kurihara I; Yokota K; Suda N; Saito I; Saruta T
J Mol Endocrinol; 2004 Feb; 32(1):69-86. PubMed ID: 14765993
[TBL] [Abstract][Full Text] [Related]
7. FHL2, UBC9, and PIAS1 are novel estrogen receptor alpha-interacting proteins.
Kobayashi S; Shibata H; Yokota K; Suda N; Murai A; Kurihara I; Saito I; Saruta T
Endocr Res; 2004 Nov; 30(4):617-21. PubMed ID: 15666801
[TBL] [Abstract][Full Text] [Related]
8. Regulation of nuclear receptor and coactivator functions by the carboxyl terminus of ubiquitin-conjugating enzyme 9.
Chang YL; Huang CJ; Chan JY; Liu PY; Chang HP; Huang SM
Int J Biochem Cell Biol; 2007; 39(5):1035-46. PubMed ID: 17336575
[TBL] [Abstract][Full Text] [Related]
9. Modulation of PLAGL2 transactivation activity by Ubc9 co-activation not SUMOylation.
Guo Y; Yang MC; Weissler JC; Yang YS
Biochem Biophys Res Commun; 2008 Sep; 374(3):570-5. PubMed ID: 18655774
[TBL] [Abstract][Full Text] [Related]
10. Identification of two independent SUMO-interacting motifs in Fas-associated factor 1 (FAF1): Implications for mineralocorticoid receptor (MR)-mediated transcriptional regulation.
Wang CH; Hung PW; Chiang CW; Lombès M; Chen CH; Lee KH; Lo YC; Wu MH; Chang WC; Lin DY
Biochim Biophys Acta Mol Cell Res; 2019 Aug; 1866(8):1282-1297. PubMed ID: 30935967
[TBL] [Abstract][Full Text] [Related]
11. 11β-HSD2 SUMOylation Modulates Cortisol-Induced Mineralocorticoid Receptor Nuclear Translocation Independently of Effects on Transactivation.
Jiménez-Canino R; Lorenzo-Díaz F; Odermatt A; Bailey MA; Livingstone DEW; Jaisser F; Farman N; Alvarez de la Rosa D
Endocrinology; 2017 Nov; 158(11):4047-4063. PubMed ID: 28938454
[TBL] [Abstract][Full Text] [Related]
12. Post-translational modification of Rta of Epstein-Barr virus by SUMO-1.
Chang LK; Lee YH; Cheng TS; Hong YR; Lu PJ; Wang JJ; Wang WH; Kuo CW; Li SS; Liu ST
J Biol Chem; 2004 Sep; 279(37):38803-12. PubMed ID: 15229220
[TBL] [Abstract][Full Text] [Related]
13. A non-covalent interaction between small ubiquitin-like modifier-1 and Zac1 regulates Zac1 cellular functions.
Liu ST; Chang YL; Wang WM; Chung MH; Lin WS; Chou WY; Huang SM
Int J Biochem Cell Biol; 2012 Mar; 44(3):547-55. PubMed ID: 22227369
[TBL] [Abstract][Full Text] [Related]
14. Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification.
Tallec LP; Kirsh O; Lecomte MC; Viengchareun S; Zennaro MC; Dejean A; Lombès M
Mol Endocrinol; 2003 Dec; 17(12):2529-42. PubMed ID: 14500761
[TBL] [Abstract][Full Text] [Related]
15. Interaction of the Mineralocorticoid Receptor With RACK1 and Its Role in Aldosterone Signaling.
Kuppusamy M; Gomez-Sanchez EP; Beloate LN; Plonczynski M; Naray-Fejes-Toth A; Fejes-Toth G; Gomez-Sanchez CE
Endocrinology; 2017 Jul; 158(7):2367-2375. PubMed ID: 28472300
[TBL] [Abstract][Full Text] [Related]
16. RAP80 interacts with the SUMO-conjugating enzyme UBC9 and is a novel target for sumoylation.
Yan J; Yang XP; Kim YS; Joo JH; Jetten AM
Biochem Biophys Res Commun; 2007 Oct; 362(1):132-138. PubMed ID: 17698038
[TBL] [Abstract][Full Text] [Related]
17. Ubc9-mediated sumoylation leads to transcriptional repression of IRF-1.
Kim EJ; Park JS; Um SJ
Biochem Biophys Res Commun; 2008 Dec; 377(3):952-6. PubMed ID: 18955028
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of a ligand-selective mineralocorticoid receptor coactivator.
Rogerson FM; Yao YZ; Young MJ; Fuller PJ
FASEB J; 2014 Oct; 28(10):4200-10. PubMed ID: 24907116
[TBL] [Abstract][Full Text] [Related]
19. Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription.
Poukka H; Aarnisalo P; Karvonen U; Palvimo JJ; Jänne OA
J Biol Chem; 1999 Jul; 274(27):19441-6. PubMed ID: 10383460
[TBL] [Abstract][Full Text] [Related]
20. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A
J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
